Zhendong Li

2PUBLICATIONS
51CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 18, 2023
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.

Yihebali Chi, Xiangqian Zheng, Yuan Zhang

|May 15, 2023
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.

Yansong Lin, Shukui Qin, Hui Yang

Pageof 1